High-Dose Rifampin Shortens Time to Tuberculosis Clearance

A combination regimen containing high-dose rifampin was associated with faster tuberculosis bacteria culture conversion in people with drug-sensitive TB, but moxifloxacin and the experimental drug SQ109 showed no benefit compared to standard therapy. An estimated 9 million people develop active TB disease each year and it remains a major cause of death for people with HIV worldwide. Current standard treatment for TB requires multiple drugs taken for 6 months or longer, which presents difficulties and toxicity.
Source : www.hivandhepatitis.com      2015/4/7 07:37

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.